Log in to save to my catalogue

Approaches to management of rhabdomyolysis as the adverse effect of drug interaction between atorvas...

Approaches to management of rhabdomyolysis as the adverse effect of drug interaction between atorvas...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8895310

Approaches to management of rhabdomyolysis as the adverse effect of drug interaction between atorvastatin and sacubitril/valsartan: a case report

About this item

Full title

Approaches to management of rhabdomyolysis as the adverse effect of drug interaction between atorvastatin and sacubitril/valsartan: a case report

Publisher

England: Oxford University Press

Journal title

European heart journal : case reports, 2022-03, Vol.6 (3), p.ytac091

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Background
Atorvastatin and sacubitril/valsartan (Entresto™) have been cornerstones in managing patients with coronary artery disease and heart failure (HF). We report a case of life-threatening rhabdomyolysis associated with the co-administration of atorvastatin and sacubitril/valsartan.
Case summary
A 58-year-old male with co...

Alternative Titles

Full title

Approaches to management of rhabdomyolysis as the adverse effect of drug interaction between atorvastatin and sacubitril/valsartan: a case report

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8895310

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8895310

Other Identifiers

ISSN

2514-2119

E-ISSN

2514-2119

DOI

10.1093/ehjcr/ytac091

How to access this item